FR2009109A1 - - Google Patents

Info

Publication number
FR2009109A1
FR2009109A1 FR6916641A FR6916641A FR2009109A1 FR 2009109 A1 FR2009109 A1 FR 2009109A1 FR 6916641 A FR6916641 A FR 6916641A FR 6916641 A FR6916641 A FR 6916641A FR 2009109 A1 FR2009109 A1 FR 2009109A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6916641A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Charles E Frosst and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charles E Frosst and Co filed Critical Charles E Frosst and Co
Publication of FR2009109A1 publication Critical patent/FR2009109A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01FMEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F9/00Measuring volume flow relative to another variable, e.g. of liquid fuel for an engine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR6916641A 1968-05-22 1969-05-22 Withdrawn FR2009109A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73133468A 1968-05-22 1968-05-22

Publications (1)

Publication Number Publication Date
FR2009109A1 true FR2009109A1 (fr) 1970-01-30

Family

ID=24939065

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6916641A Withdrawn FR2009109A1 (fr) 1968-05-22 1969-05-22

Country Status (12)

Country Link
US (1) US3655661A (fr)
BE (1) BE733389A (fr)
CH (1) CH517110A (fr)
DE (1) DE1925989A1 (fr)
DK (1) DK125025B (fr)
ES (1) ES367521A1 (fr)
FR (1) FR2009109A1 (fr)
GB (1) GB1250981A (fr)
IL (1) IL32204A0 (fr)
NL (1) NL6907075A (fr)
NO (1) NO125534B (fr)
ZA (1) ZA693639B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2404858A1 (de) 1974-02-01 1975-08-07 Boehringer Mannheim Gmbh Aminderivate des 4-hydroxy-2,1,3-benzthiadiazols und verfahren zu ihrer herstellung
DE2943406A1 (de) * 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
US4395556A (en) * 1982-02-04 1983-07-26 E. R. Squibb & Sons, Inc. Nitrobenzofurazan derivatives
US4728651A (en) * 1985-10-24 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. Antihypertensive thieno-isoxazoles and -pyrazoles
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE651032A (fr) * 1963-07-30 1965-01-27

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE651032A (fr) * 1963-07-30 1965-01-27

Also Published As

Publication number Publication date
IL32204A0 (en) 1969-07-30
CH517110A (de) 1971-12-31
DK125025B (da) 1972-12-18
NO125534B (fr) 1972-09-25
GB1250981A (fr) 1971-10-27
BE733389A (fr) 1969-11-21
DE1925989A1 (de) 1969-11-27
US3655661A (en) 1972-04-11
ZA693639B (en) 1971-01-27
NL6907075A (fr) 1969-11-25
ES367521A1 (es) 1971-07-16

Similar Documents

Publication Publication Date Title
AU428130B2 (fr)
AU5184069A (fr)
AU6168869A (fr)
FR2009109A1 (fr)
AU6171569A (fr)
AU429879B2 (fr)
AU4304568A (fr)
AU4811568A (fr)
AU421558B1 (fr)
AU2580267A (fr)
AU4744468A (fr)
BE708888A (fr)
AU4270368A (fr)
BE630165A (fr)
BE709320A (fr)
BE581157A (fr)
BE728539A (fr)
BE708933A (fr)
BE708951A (fr)
AU5758767A (fr)
BE709095A (fr)
BE709119A (fr)
BE709138A (fr)
AU479894A (fr)
AU479393A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse